Bronchiectasis

JD Chalmers, AB Chang, SH Chotirmall… - Nature reviews Disease …, 2018 - nature.com
Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …

The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions

E Polverino, K Dimakou, J Hurst… - European …, 2018 - Eur Respiratory Soc
Bronchiectasis is a clinical and radiological diagnosis associated with cough, sputum
production and recurrent respiratory infections. The clinical presentation inevitably overlaps …

[HTML][HTML] Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

JD Chalmers, E Polverino, ML Crichton… - The Lancet …, 2023 - thelancet.com
Background Bronchiectasis is a heterogeneous, neglected disease with few multicentre
studies exploring the causes, severity, microbiology, and treatment of the disease across …

[HTML][HTML] British Thoracic Society Guideline for bronchiectasis in adults

AT Hill, AL Sullivan, JD Chalmers, A De Soyza… - Thorax, 2019 - thorax.bmj.com
CT scanning can also aid in identifying an aetiology of bronchiectasis eg Allergic
bronchopulmonary aspergillosis (ABPA), Non-tuberculous mycobacteria (NTM), primary …

European Respiratory Society guidelines for the management of adult bronchiectasis

E Polverino, PC Goeminne… - European …, 2017 - Eur Respiratory Soc
Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

[HTML][HTML] Bronchiectasis in India: results from the European multicentre bronchiectasis audit and research collaboration (EMBARC) and respiratory research network of …

R Dhar, S Singh, D Talwar, M Mohan… - The Lancet Global …, 2019 - thelancet.com
Background Bronchiectasis is a common but neglected chronic lung disease. Most
epidemiological data are limited to cohorts from Europe and the USA, with few data from low …

Characterization of the “frequent exacerbator phenotype” in bronchiectasis

JD Chalmers, S Aliberti, A Filonenko… - American journal of …, 2018 - atsjournals.org
Rationale: Exacerbations are key events in the natural history of bronchiectasis, but clinical
predictors and outcomes of patients with frequently exacerbating disease are not well …

[HTML][HTML] Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis

R Chandrasekaran, M Mac Aogáin, JD Chalmers… - BMC pulmonary …, 2018 - Springer
Bronchiectasis is a disease associated with chronic progressive and irreversible dilatation of
the bronchi and is characterised by chronic infection and associated inflammation. The …

[HTML][HTML] Just breathe: a review of sex and gender in chronic lung disease

R Somayaji, JD Chalmers - European Respiratory Review, 2022 - Eur Respiratory Soc
Chronic lung diseases are the third leading cause of death worldwide and are increasing in
prevalence over time. Although much of our traditional understanding of health and disease …

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis

IF Laska, ML Crichton, A Shoemark… - The lancet respiratory …, 2019 - thelancet.com
Background Although use of inhaled antibiotics is the standard of care in cystic fibrosis,
there is insufficient evidence to support use of inhaled antibiotics in patients with …